Corona Virus Disease-2019 pandemic: Planning and implementing a scientific approach to introduce or revoke public health and social interventions

Author(s):  
Saurabh Shrivastava ◽  
Prateek Shrivastava
2020 ◽  
Vol 32 (3) ◽  
pp. 109-111
Author(s):  
Adamson Muula

Many of us have heard and said that the best approach to defeating the Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-Cov2) and novel Corona virus disease of 2019 (Covid-19) is to let public health and science guide the response. Others have invoked both public health and science.. They have said that public health or science should drive the (national or global) response.


PLoS ONE ◽  
2021 ◽  
Vol 16 (3) ◽  
pp. e0243265
Author(s):  
Neta S. Zuckerman ◽  
Efrat Bucris ◽  
Yaron Drori ◽  
Oran Erster ◽  
Danit Sofer ◽  
...  

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) which causes corona virus disease (COVID-19) was first identified in Wuhan, China in December 2019 and has since led to a global pandemic. Importations of SARS-CoV-2 to Israel in late February from multiple countries initiated a rapid outbreak across the country. In this study, SARS-CoV-2 whole genomes were sequenced from 59 imported samples with a recorded country of importation and 101 early circulating samples in February to mid-March 2020 and analyzed to infer clades and mutational patterns with additional sequences identified Israel available in public databases. Recorded importations in February to mid-March, mostly from Europe, led to multiple transmissions in all districts in Israel. Although all SARS-CoV-2 defined clades were imported, clade 20C became the dominating clade in the circulating samples. Identification of novel, frequently altered mutated positions correlating with clade-defining positions provide data for surveillance of this evolving pandemic and spread of specific clades of this virus. SARS-CoV-2 continues to spread and mutate in Israel and across the globe. With economy and travel resuming, surveillance of clades and accumulating mutations is crucial for understanding its evolution and spread patterns and may aid in decision making concerning public health issues.


2021 ◽  
Vol 7 (2) ◽  
pp. 30-32
Author(s):  
Z Habib ◽  
◽  
Y Hafeez ◽  
Imen Mbarek ◽  
M Ul Haque ◽  
...  

WHO declared Corona Virus disease 2019 (COVID-19) as a public health emergency on the 30th of January 2020. Soon afterward, COVID-19 cases started to emerge from all parts of the world. The state of Qatar was extremely vigilant from the very outset. Special measures were introduced immediately to restrict the influx of people from high-risk countries such as China and Iran. The Ministry of public health (MOPH), Qatar started preparing for an impending pandemic in the meantime. The first cluster of COVID-19 positive cases was declared on March the 11th 2019. A total of 238 cases were declared positive on this day. It raised the alarm to roll over all those preparations on the ground into practice


2021 ◽  
Vol 251 ◽  
pp. 02038
Author(s):  
Ting Wang ◽  
Qiuxin Wang ◽  
Jinwen Wang

As a public health emergency with strong infectious, corona virus disease (COVID-19) in Wuhan,Hubei in December 2019 has attracted worldwide concern. The epidemiological features of COVID- 19 in China at the early stage are examined. The spread of COVID-19 has reached a peak in China. The epidemic situation is very severe, especially in the regions or central cities closely linked with Wuhan. The increase in cure rate of COVID-19 also predicts a reduction in the risk of fatality.


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1171-1174
Author(s):  
Shruti Sadavarte ◽  
Bhagyashri Vijay Chaudhari

Human history is observing a very horrible and strange situation fighting a very small enemy. The Novel COVID-19 corona virus. On 11 feb 2020 world health organization has declared a name for covid disorder and has said covid as a global public health diease and also as a pandemic due to its worldwide spread. It started as an outbreak in december with its birth place in wuhan people of china has came out as a global public health exigency of worldwide trouble. Corona virus are the group of virus with non segmented, single stranded and positive sence RNA genome. In this narrative review article, reference was taken from different article published in various database. Maximum article including the information of pregnancy and covid-19 were reviewed. A review of 11article with world health organization site information it is found that the symptoms of corona virus disease in non-pregnant occurred indistinguishable to that of gravid mother. There is no information regarding perinatal transmission in parturiency. It has been disclosed that corona virus can cause distress in gravid mother, miscarriage and also fetal distress. In general due to lack of relevant information regarding the effect of corona virus disease on gravidity it is obligatory to have more and more studies in this area.


Author(s):  
Ramya R. Iyer

The novel corona virus disease (COVID-19) is a pandemic and has been declared as a Public Health Emergency of International Concern. There is a need for consolidation of global guidelines to prevent and reduce the transmission of this disease at individual, community, national and international level. Health care workers on one hand shoulder the responsibility of mitigation and on the other hand are themselves vulnerable, given the possibility of improper case detection and unascertained modes of transmission of this not well- known viral strain. This review provides a synthesis of facts, news and information on published and unpublished forums about COVID-19 and also throws light upon the various standards and protocols for prevention and management of patients through public health action, meticulous precautions recommended in clinical and community settings, as applicable to dental and other health care professionals.


Author(s):  
Divya RSJB Rana ◽  
Santosh Dulal

AbstractThe corona virus disease -2019 (COVID-19) pandemic has caused a massive global public health havoc. Recent published clinical trials show conflicting data for use of chloroquine/hydroxychloroquine for COVID-19. This study meticulously evaluated the various dosages of chloroquine and hydroxychloroquine utilized in clinical trials registered in Chinese and US clinical trial registries for the treatment of pneumonia caused by SARS-CoV-2. Moreover, the results of published clinical trials and in vitro studies using chloroquine and hydroxychloroquine relevant to the disease are discussed.


Sign in / Sign up

Export Citation Format

Share Document